This is the authors' abstract. We don't add key points for this paper.
Objective To evaluate the inhibitory effect of Chlorogenic acid (CGA) on the biofilm formation in periprosthetic joint infection (PJI) using OD₄₉₂ values, and to analyze the differences in the inhibitory effects of CGA at different concentrations on pathogenic bacterial biofilms during PJI. Methods Five of the most common PJI-causing bacteria were selected. The experimental included a non-intervention control group, a 50 µg/mL CGA group, and a 200 µg/mL CGA group, with 21 samples in each group. The bacteria were cultured at 37°C in monoclonal TSB broth. Glass slides were placed in the cultures and incubated at 37°C with constant shaking for 48 hours to form biofilms, establishing in vitro model of PJI. CGA was dissolved in dimethyl sulfoxide (DMSO) and diluted to different concentrations (50, 200 µg/mL) in TSB. The OD₄₉₂ values of the bacterial suspension samples were measured using a microplate reader. Results The non-intervention control group showed an OD₄₉₂ value of 0.461 ± 0.02 (21 samples), the 50 µg/mL CGA group had an OD₄₉₂ value of 0.351 ± 0.04 (21 samples), and the 200 µg/mL CGA group had an OD₄₉₂ value of 0.322 ± 0.03 (21 samples). One-way analysis of variance showed P < 0.001, and independent sample t-tests between the 50 µg/mL CGA group and the 200 µg/mL CGA group showed a P-value of 0.019 (P < 0.05). Conclusion Both 50 µg/mL and 200 µg/mL concentrations of CGA can inhibit biofilm formation by pathogenic bacteria in PJI. In the PJI process, 200 µg/mL CGA has a stronger inhibitory effect on bacterial biofilm formation than 50 µg/mL CGA.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Jie Lin (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: